Advisor Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2K | Sell |
2,884
-302
| -9% | -$209 | ﹤0.01% | 4938 |
|
|
2019
Q3 | $3K | Buy |
3,186
+300
| +10% | +$282 | ﹤0.01% | 4824 |
|
|
2019
Q2 | $3K | Buy |
2,886
+302
| +12% | +$314 | ﹤0.01% | 4851 |
|
|
2019
Q1 | $3K | Sell |
2,584
-666
| -20% | -$773 | ﹤0.01% | 4836 |
|
|
2018
Q4 | $3K | Sell |
3,250
-465
| -13% | -$429 | ﹤0.01% | 4701 |
|
|
2018
Q3 | $8K | Hold |
3,715
| – | – | ﹤0.01% | 4377 |
|
|
2018
Q2 | $7K | Hold |
3,715
| – | – | ﹤0.01% | 4245 |
|
|
2018
Q1 | $9K | Sell |
3,715
-1,143
| -24% | -$2.77K | ﹤0.01% | 4136 |
|
|
2017
Q4 | $9K | Buy |
4,858
+1,143
| +31% | +$2.12K | ﹤0.01% | 4138 |
|
|
2017
Q3 | $9K | Buy |
3,715
+800
| +27% | +$1.94K | ﹤0.01% | 4040 |
|
|
2017
Q2 | $8K | Buy |
+2,915
| New | +$8K | ﹤0.01% | 4038 |
|
|
2016
Q3 | – | Sell |
-457
| Closed | -$1K | – | 4530 |
|
|
2016
Q2 | $1K | Buy |
+457
| New | +$1K | ﹤0.01% | 4225 |
|